OPK has 36-month beta value of 1.63. Analysts have mixed views on the stock, with 2 analysts rating it as a “buy,” 4 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for OPK is 318.10M, and currently, short sellers hold a 30.14% ratio of that float. The average trading volume of OPK on November 25, 2024 was 3.60M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
OPK) stock’s latest price update
The stock of Opko Health Inc (NASDAQ: OPK) has increased by 3.80 when compared to last closing price of 1.58. prnewswire.com reported 2024-11-18 that OPKO Healthcare’s Veterinary Care Products to be Introduced at Asia’s Largest Health and Nutrition Tradeshow Company Invited to Present at Special Event Hosted by U.S. Consulate General During the Expo COCONUT GROVE, Fla., Nov. 18, 2024 /PRNewswire/ — NextPlat Corp (NASDAQ: NXPL, NXPLW) (“NextPlat” or the “Company”), a global e-commerce provider, today announced that it is participating in the 2024 China International Natural Health & Nutrition Expo (NHNE), Asia’s largest exhibition focused on the sales and marketing of health, nutrition and dietary supplement products, as the Company continues to ramp-up sales and promotional activities in China.
OPK’s Market Performance
Opko Health Inc (OPK) has seen a 0.00% fall in stock performance for the week, with a 15.49% gain in the past month and a -0.61% plunge in the past quarter. The volatility ratio for the week is 3.76%, and the volatility levels for the past 30 days are at 5.49% for OPK. The simple moving average for the past 20 days is 5.20% for OPK’s stock, with a 21.72% simple moving average for the past 200 days.
Analysts’ Opinion of OPK
Many brokerage firms have already submitted their reports for OPK stocks, with Barrington Research repeating the rating for OPK by listing it as a “Outperform.” The predicted price for OPK in the upcoming period, according to Barrington Research is $2 based on the research report published on June 29, 2023 of the previous year 2023.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see OPK reach a price target of $3. The rating they have provided for OPK stocks is “Buy” according to the report published on December 15th, 2022.
OPK Trading at 8.04% from the 50-Day Moving Average
After a stumble in the market that brought OPK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.02% of loss for the given period.
Volatility was left at 5.49%, however, over the last 30 days, the volatility rate increased by 3.76%, as shares surge +9.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading unchanged at present.
During the last 5 trading sessions, OPK remain unchanged, which changed the moving average for the period of 200-days by +56.19% in comparison to the 20-day moving average, which settled at $1.5590. In addition, Opko Health Inc saw 8.61% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OPK starting from FROST PHILLIP MD ET AL, who purchase 100,000 shares at the price of $1.59 back on Nov 22 ’24. After this action, FROST PHILLIP MD ET AL now owns 211,712,405 shares of Opko Health Inc, valued at $159,000 using the latest closing price.
FROST PHILLIP MD ET AL, the CEO & Chairman of Opko Health Inc, purchase 100,000 shares at $1.62 during a trade that took place back on Nov 14 ’24, which means that FROST PHILLIP MD ET AL is holding 211,612,405 shares at $161,980 based on the most recent closing price.
Stock Fundamentals for OPK
Current profitability levels for the company are sitting at:
- -0.26 for the present operating margin
- 0.2 for the gross margin
The net margin for Opko Health Inc stands at -0.19. The total capital return value is set at -0.09. Equity return is now at value -9.39, with -6.20 for asset returns.
Based on Opko Health Inc (OPK), the company’s capital structure generated 0.28 points at debt to capital in total, while cash flow to debt ratio is standing at -0.33. The debt to equity ratio resting at 0.38. The interest coverage ratio of the stock is -5.13.
Currently, EBITDA for the company is -65.52 million with net debt to EBITDA at -2.33. When we switch over and look at the enterprise to sales, we see a ratio of 1.75. The receivables turnover for the company is 5.13for trailing twelve months and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.97.
Conclusion
To put it simply, Opko Health Inc (OPK) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
